MRK: Merck & Co., Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 270,004.69
Enterprise Value ($M) 288,068.69
Book Value ($M) 44,524.00
Book Value / Share 17.54
Price / Book 6.06
NCAV ($M) -27,380.00
NCAV / Share -10.79
Price / NCAV -9.86

Profitability (mra)
Return on Invested Capital (ROIC) 0.19
Return on Assets (ROA) 0.14
Return on Equity (ROE) 0.38

Liquidity (mrq)
Quick Ratio 1.23
Current Ratio 1.47

Balance Sheet (mrq) ($M)
Current Assets 35,722.00
Assets 109,160.00
Liabilities 63,102.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 59,283.00
Operating Income 22,801.00
Net Income 14,519.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 19,095.00
Cash from Investing -4,960.00
Cash from Financing -9,119.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-09 13G/A Vanguard Group Inc 8.96 7.58
02-03 13G/A BlackRock Inc. 8.50 8.47

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-03-31 581,314 3,935,547 14.77
2023-03-30 552,862 3,845,182 14.38
2023-03-29 444,471 4,326,614 10.27
2023-03-28 720,676 4,413,460 16.33
2023-03-27 632,113 5,276,643 11.98

(click for more detail)

Similar Companies
JNJ – Johnson & Johnson LCI – Lannett Company, Inc.
LLY – Eli Lilly And Co MYOV – Myovant Sciences Ltd.
NUVB – Nuvation Bio Inc


Financial data and stock pages provided by
Fintel.io


Finpedia: Merck & Co